CYTOKINETICS, INCORPORATED23282W605US23282W605705/27/2026To approve, on an advisory basis, the compensation of the Company's named executive offi cers, as disclosed in the Proxy StatementSECTION 14A SAY-ON-PAY VOTES1800000FOR180000FORDISC MEDICINE, INC.254604101US254604101106/18/2026To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES400000FOR40000FORREVOLUTION MEDICINES INC.76155X100US76155X100006/24/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").SECTION 14A SAY-ON-PAY VOTES4083530FOR408353FORRHYTHM PHARMACEUTICALS, INC.76243J105US76243J105106/24/2026Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the CompanySECTION 14A SAY-ON-PAY VOTES11876660FOR1187666FORTREVI THERAPEUTICS, INC.89532M101US89532M101806/03/2026Advisory approval of compensation paid to named executive officersSECTION 14A SAY-ON-PAY VOTES500000FOR50000FOR